Kathpal Madeera, Tinnel Brent, Sun Kelly, Ninneman Stephanie, Malmer Cynthia, Wendt Stacie, Buff Sheena, Valentich David, Gossweiler Marisa, Macdonald Dusten
Department of Radiation Oncology, Fort Belvoir Community Hospital, Fort Belvoir, Virginia.
Department of Radiation Oncology, Madigan Army Medical Center, Tacoma, Washington.
Pract Radiat Oncol. 2016 Sep-Oct;6(5):e195-e202. doi: 10.1016/j.prro.2015.12.008. Epub 2016 Jan 4.
With most patients now living long after their breast cancer diagnosis, minimizing long-term side effects of breast cancer treatment, such as reducing late cardiac and pulmonary side effects of radiation therapy (RT), is particularly important. It is now possible to use an electromagnetic tracking system to allow real-time tracking of chest wall (CW) position during the delivery of RT. Here, we report our experience using electromagnetic surface transponders as an added measure of CW position during deep inspiration breath hold (DIBH).
We conducted a single-institution institutional review board-approved retrospective review of 15 female left-sided breast cancer patients treated between July 2012 and June 2013 with conventional whole breast radiation. We compared daily port films with treatment planning digitally reconstructed radiographs to establish daily setup accuracy, then used Calypso tracings to compare the position of the CW during the daily port film with the position of the CW during that day's treatment to determine the reproducibility of the breath hold position. Finally, we created competing treatment plans not using DIBH and used a paired t test to compare mean heart (MH) and left anterior descending (LAD) coronary artery dose between the 2 techniques.
Mean total error (inter- and intrafraction) was dominated by interfraction error and was greatest in the longitudinal direction with a mean of 2.13 mm and 2 standard deviations of 8.2 mm. DIBH significantly reduced MH and LAD dose versus free breathing plans (MH, 1.26 Gy vs 2.84 Gy, P ≤ .001; LAD, 5.49 Gy vs 18.15 Gy, P ≤ .001).
This study demonstrates that DIBH with electromagnetic confirmation of CW position is feasible, and allows potential improvement in the accurate delivery of adjuvant RT therapy for breast cancer.
由于现在大多数乳腺癌患者在确诊后能长期存活,将乳腺癌治疗的长期副作用降至最低,比如减少放射治疗(RT)的晚期心脏和肺部副作用,就显得尤为重要。现在可以使用电磁跟踪系统在RT过程中实时跟踪胸壁(CW)位置。在此,我们报告使用电磁表面应答器作为深吸气屏气(DIBH)期间CW位置的附加测量方法的经验。
我们对2012年7月至2013年6月期间接受常规全乳放疗的15例左侧乳腺癌女性患者进行了一项单机构机构审查委员会批准的回顾性研究。我们将每日射野片与治疗计划数字重建射线照片进行比较,以确定每日摆位精度,然后使用Calypso追踪来比较每日射野片期间CW的位置与当天治疗期间CW的位置,以确定屏气位置的可重复性。最后,我们制定了不使用DIBH的竞争性治疗计划,并使用配对t检验比较两种技术之间的平均心脏(MH)和左前降支(LAD)冠状动脉剂量。
平均总误差(分次间和分次内)以分次间误差为主,在纵向方向上最大,平均值为2.13 mm,标准差为8.2 mm。与自由呼吸计划相比,DIBH显著降低了MH和LAD剂量(MH,1.26 Gy对2.84 Gy,P≤0.001;LAD,5.49 Gy对18.15 Gy,P≤0.001)。
本研究表明,通过电磁确认CW位置的DIBH是可行的,并且可能改善乳腺癌辅助RT治疗的精确实施。